February 27, 2015 Effect of low serum total bilirubin levels (≤0.32 mg/dl) on risk of coronary artery disease in patients with metabolic syndrome. Am J Cardiol. 2014;114:1695-700
Song YS, Koo BK, Cho NH, Moon MK
February 27, 2015 Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford exercise testing project). Am J Cardiol. 2014;114:1701-6
Aladin AI, Whelton SP, Al-Mallah MH, Blaha MJ, Keteyian SJ, Juraschek SP, Rubin J, Brawner CA, Michos ED
February 27, 2015 Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens. 2014;32:2285-95
Thomopoulos C, Parati G, Zanchetti A
February 26, 2015 Guidelines in the USA, a viewpoint contrary to those guidelines in Europe, Canada, Britain and the International Atherosclerosis Society. Curr Opin Lipidol. 2014;25:413-7
Saraf S, Ray KK
Keep up with all the latest from the cardiometabolic world. For breaking news, website updates and exclusive invitations to events with your peers.
Expert Opinions How do you see the future in Asia in terms of clinical practice and public health relevant to management/prevention of diabetes?
Juliana C N Chan, MBChB, MD, FRCP Professor of Medicine & Therapeutics, Director, Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China
Expert Opinions Does the quality of subcutaneous adipose tissue have implications regarding the way we assess and manage obesity?
Fredrik Karpe, PhD, FRCP, Professor, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK
Expert Opinions Could you comment on the adipogenic potential of subcutaneous adipose tissue as it relates to health?
André Tchernof, PhD, Department of Nutrition, Université Laval, Endocrinology and Genomics axis, Laval University Medical Centre, Québec, QC, Canada
In the Spotlight
Expert Opinions What are the treatment modalities that can reduce ectopic fat?
Amalia Gastaldelli, PhD, Research Director, Cardiometabolic Risk Laboratory, Institute of Clinical Physiology of CNR, Pisa, Italy
Luc Van Gaal, MD, PhD, Professor of Medicine, Antwerp University Hospital, Faculty of Medicine, Department of Diabetology, Metabolism & Clinical Nutrition, Antwerp, Belgium
The International Chair on Cardiometabolic Risk